West Nile virus central nervous system infection in patients treated with rituximab: Implications for diagnosis and prognosis, with a review of literature Journal Article

   

Authors:	Morjaria, S.; Arguello, E.; Taur, Y.; Sepkowitz, K.; Hatzoglou, V.; Nemade, A.; Rosenblum, M.; Cavalcanti, M. S.; Lia Palomba, M.; Kaltsas, A.
Article Title:	West Nile virus central nervous system infection in patients treated with rituximab: Implications for diagnosis and prognosis, with a review of literature
Abstract:	The spectrum of West Nile virus (WNV) infection continues to be elucidated. Many cases of WNV are asymptomatic; however, in immunocompromised patients, symptoms are more likely to be severe. We describe fatal WNV central nervous system disease in lymphoma patients who received rituximab, blunting the inflammatory response and complicating diagnosis. © The Author 2015.
Keywords:	rituximab; lymphoma; immunocompromised host; west nile virus; molecular testing
Journal Title:	Open Forum Infectious Diseases
Volume:	2
Issue:	4
ISSN:	2328-8957
Publisher:	Oxford University Press
Date Published:	2015-01-01
Start Page:	ofv136
Language:	English
DOI:	10.1093/ofid/ofv136
PROVIDER:	scopus
PMCID:	PMC4643542
PUBMED:	26576450
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85014199950&doi=10.1093%2fofid%2fofv136&partnerID=40&md5=0213e8eb0efbe29c0387ffe28ba79608
Notes:	Article -- Export Date: 3 April 2017 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/108292